LAURA SCHIFF: Open Payments
NPI 1558904177 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,668 in 240 payments from 35 companies in 2025. Trend: 2023 $5,024 · 2024 $3,827 · 2025 $4,668
Food & beverage: $4,668
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $803 |
| Amgen Inc. | 39 | $499 |
| Novo Nordisk Inc | 20 | $420 |
| PFIZER INC. | 27 | $397 |
| Madrigal Pharmaceuticals | 5 | $353 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $275 |
| Lilly USA, LLC | 13 | $172 |
| Vanda Pharmaceuticals Inc. | 9 | $163 |
| AstraZeneca Pharmaceuticals LP | 4 | $155 |
| Eisai Inc. | 2 | $142 |
Products named: EVENITY, REZDIFFRA, UBRELVY, NURTEC ODT, JARDIANCE, Rybelsus, QULIPTA, FANAPT.
Industry payments across CA — which companies pay providers there.
